Abstract
The aim of this study was to determine whether eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), or both, were responsible for the triglyceride (TG)-lowering effects of fish oil. EPA (91% pure) and DHA (83% pure), a fish oil concentrate (FOC; 41% EPA and 23% DHA) and an olive oil (OO) placebo (all ethyl esters) were tested. A total of 49 normolipidemic subjects participated. Each subject was given placebo for 2–3 wk and one of the n-3 supplements for 3 wk in randomized, blinded trials. The target n-3 fatty acid (FA) intake was 3 g/day in all studies. Blood samples were drawn twice at the end of each supplementation phase and analyzed for lipids, lipoproteins, and phospholipid FA composition. In all groups, the phospholipid FA composition changed to reflect the n-3 FA given. On DHA supplementation, EPA levels increased to a small but significant extent, suggesting that some retroconversion may have occurred. EPA supplementation did not raise DHA levels, however, FOC and EPA produced significant decreases in both TG and very low density lipoprotein (VLDL) cholesterol (C) levels (P<0.01) and increases in low density lipoprotein (LDL) cholesterol levels (P<0.05). DHA supplementation did not affect cholesterol, triglyceride, VLDL, LDL, or high density lipoprotein (HDL) levels, but it did cause a significant increase in the HDL2/HDL3 cholesterol ratio. We conclude that EPA appears to be primarily responsible for TG-lowering (and LDL-C raising) effects of fish oil.
Similar content being viewed by others
Abbreviations
- C:
-
cholesterol
- DHA:
-
docosahexaenoic acid
- EPA:
-
eicosapentaenoic acid
- FA:
-
fatty acids
- FOC:
-
fish oil concentrate
- HDL:
-
high density lipoproteins
- LDL:
-
low density lipoproteins
- LpL:
-
lipoprotein lipase
- OO:
-
olive oil
- TG:
-
triglyceride
- VLDL:
-
very low density lipoproteins
References
Harris, W.S. (1989) Fish Oils and Plasma Lipid and Lipoprotein Metabolism in Humans: A Critical Review,J. Lipid Res. 30, 785–807.
Nagakawa, Y., Orimo, H., Harasawa, M., Morita, I., Yashiro, K., and Murota, S. (1983) Effect of Eicosapentaenoic Acid on the Platelet Aggregation and Composition of Fatty Acid in Man: A Double Blind Study,Atherosclerosis 47, 71–75.
Homma, Y., Ohshima, K., Yamaguchi, H., Nakamura, H., Araki, G., and Goto, Y. (1991) Effects of Eicosapentaenoic Acid on Plasma Lipoprotein Subfractions and Activities of Lecithin: Cholesterol Acyltransferase and Lipid Transfer Protein,Atherosclerosis 91, 145–153.
Hawthorne, A.B., Filipowicz, B.L., Edwards, T.J., and Hawkey, C.J. (1990) High Dose Eicosapentaenoic Acid Ethyl Ester: Effects on Lipids and Neutrophil Leukotriene Production in Normal Volunteers.Br. J. Clin. Pharmac. 30, 187–194.
Terano, T., Hirai, A., Hamazaki, T., Kobayashi, S., Fujita, T., Tamura, Y., and Kumagai, A. (1983) Effect of Oral Administration of Highly Purified Eicosapentaenoic Acid on Platelet Function, Blood Viscosity and Red Cell Deformability in Health Human Subjects,Atherosclerosis 46, 321–331.
Hamazaki, T., Takazakura, E., Osawa, K., Urakaze, M., and Yano, S. (1990) Reduction in Microalbuminuria in Diabetics by Eicosapentaenoic Acid Ethyl Ester,Lipids 25, 541–545.
Nozaki, S., Matsuzawa, Y., Hirano, K.I., Sakai, N., Kubo, M., and Tarui, S. (1992) Effects of Purified Eicosapentaenoic Acid Ethyl Ester on Plasma Lipoproteins in Primary Hypercholesterolemia,Int. J. Vit. Nutr. Res. 62, 256–260.
Shimizu, H., Sato, N., Tanaka, Y., Kashima, K., Ohtani, K.I., and Mori, M. (1993) Effect of Eicosapentaenoic Acid Ethyl on Urine Albumin Excretion in NIDDM,Diab. Care 16, 1406–1408.
Wojenski, C.M., Silver, M.J., and Walker, J. (1991) Eicosapentaenoic Acid Ethyl Ester as an Antithrombotic Agent: Comparison to an Extract of Fish Oil,Biochim. Biophys. Acta 1081, 33–38.
Harris, W.S., and Muzio, F. (1993) Fish Oil Reduces Post-prandial Triglyceride Concentrations Without Accelerating Lipid Emulsion Removal Rates,Am. J. Clin. Nutr. 58, 68–74.
Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge,Clin. Chem. 19, 499–502.
Childs, M.T., King, I.B., and Knopp, R.H. (1990) Divergent Lipoprotein Responses to Fish Oils with Various Ratios of Eicosapentaenoic Acid and Docosahexaenoic Acid,Am. J. Clin. Nutr. 52, 632–639.
Kobatake, Y., Kuroda, K., **nouchi, H., Nishida, E., and Innami, S. (1984) Differential Effects of Dietary Eico-sapentaenoic and Docosahexaenoic Fatty Acids on Lowering of Triglyceride and Cholesterol Levels in the Serum of Rats on Hypercholesterolemic Diet,J. Nutr. Sci. Vitaminol. Tokyo 30, 357–372.
Demoz, A., Willumsen, N., and Berge, R.K. (1992) Eicosapentaenoic Acid at Hypotriglyceridemic Dose Enhances the Hepatic Antioxidant Defense in Mice,Lipids 27, 968–971.
Freidreich, E.J., Gehan, E.A., Rall, D.P., Schmidt, L.H., and Skipper, H.E. (1966) Quantitative Comparison of Toxicity of Anticancer Agents in Mouse, Rat, Hamster, Dog, Monkey, and Man,Cancer Chemotherapy Reports 50, 219–245.
Lang, C.A., and Davis, R.A. (1990) Fish Oil Fatty Acids Impair VLDL Assembly and/or Secretion by Cultured Rat Hepatocytes,J. Lipid Res. 31, 2079–2086.
Rustan, A.C., Nossen, J.O., Christiansen, E.N., and Drevon, C.A. (1988) Eicosapentaenoic Acid Reduces Hepatic Synthesis and Secretion of Triacylglycerol by Decreasing the Activity of Acyl-Coenzyme A:1,2-Diacylglycerol Acyltransferase,J. Lipid Res. 29, 1417–1426.
Benner, K., Sasaki, A., Gowen, D.R., Weaver, A., and Connor, W.E. (1990) The Differential Effect of Eicosapentaenoic Acid and Oleic Acid on Lipid Synthesis and VLDL Secretion in Rabbit Hepatocytes,Lipids 25, 534–540.
Wong, S., Fisher, E.A., and Marsh, J.B. (1989) Effects of Eicosapentaenoic and Docosahexaenoic Acids on Apoprotein B mRNA and Secretion of Very Low Density Lipoprotein in HepG2 Cells,Arteriosclerosis 9, 836–841.
Wong, S., and Nestel, P.J. (1987) Eicosapentaenoic Acid Inhibits the Secretion of Triacylglycerol and of Apoprotein B and the Binding of LDL in HepG2 Cells,Atherosclerosis 64, 139–146.
Wong, S.H., Nestel, P.J., Trimble, R.P., Storer, G.B., Illman, R.J., and Top**, D.L. (1984) The Adaptive Effects of Dietary Fish and Safflower Oil on Lipid and Lipoprotein Metabolism in Perfused Rat Liver,Biochim. Biophys. Acta 792, 103–109.
Zhang, Z.J., Wilcox, H.G., Castellani, L., Fungwe, T.V., Elam, M.B., and Heimberg, M. (1993) Concentration-Dependent Effects of Eicosapentaenoic Acid on Very Low Density Lipoprotein Secretion by the Isolated Perfused Rat Liver,Lipids 28, 419–425.
Martin, L.J., Reaidi, G.B., Gavino, G.R., and Gavino, V.C. (1991) Effect of 4,7,10,13,16,19-Docosahexaenoic Acid on Triglyceride Accumulation and Secretion in Rat Hepatocytes in Culture,Lipids 26, 374–380.
Sullivan, D.R., Sanders, T.A.B., Trayner, I.M., and Thompson, G.R. (1986) Paradoxical Elevation of LDL Apoprotein B Levels in Hypertriglyceridaemic Patients and Normal Subjects Ingesting Fish Oil,Atherosclerosis 61, 129–134.
Packard, C.J., Munro, A., Lorimer, A.R., Gotto, A.M., and Shepherd, C.J. (1984) Metabolism of Apolipoprotein B in Large, Triglyceride-Rich Very Low Density Lipoproteins of Normal and Hypertriglyceridemic Subjects,J. Clin. Invest. 74, 2178–2192.
Inagaki, M., and Harris, W.S. (1990) Changes in Lipoprotein Composition in Hypertriglyceridemic Patients Taking Cholesterol-Free Fish Oil Supplements,Atherosclerosis 82, 237–246.
Harris, W.S., Connor, W.E., Alam, N., and Illingworth, D.R. (1988) Reduction of Postprandial Triglyceridemia in Humans by Dietary ω-3 Fatty Acids,J. Lipid Res. 29, 1451–1460.
Weintraub, M.S., Zechner, R., Brown, A., Eisenberg, S., and Breslow, J.L. (1988) Dietary Polyunsaturated Fats of the ω-6 and ω-3 Series Reduce Postprandial Lipoprotein Levels,J. Clin. Invest 82, 1884–1893.
Nozaki, S., Garg, A., Vega, G.L., and Grundy, S.M. (1991) Postheparin Lipolytic Activity and Plasma Lipoprotein Response to ω-3 Polyunsaturated Fatty Acids in Patients with Primary Hypertriglyceridemia,Am. J. Clin. Nutr. 53, 638–642.
Haug, A., and Hostmark, A.T. (1987) Lipoprotein Lipases, Lipoproteins and Tissue Lipids in Rats Fed Fish Oil or Coconut Oil,J. Nutr. 117, 1011–1017.
Daggy, B., Arost, C., and Bensadoun, A. (1987) Dietary Fish Oil Decreases VLDL Production Rates, Biochim Biophys Acta 920 293–300.
Huff, M.W., Telford, D.E., Edmonds, B.W., McDonald, C.G., and Evans, A.J. (1993) Lipoprotein Lipases, Lipoprotein Density Gradient Profile and LDL Receptor Activity in Miniature Pigs Fed Fish Oil and Corn Oil,Biochim. Biophys. Acta 1210, 113–122.
Harris, W.S., Lu, G.P., and Windsor, S.L. (1995) Fish Oil Accelerates the Conversion of VLDL to LDLin Vitro, J. Invest. Med. 43, 302A (Abstract).
Roach, P.D., Kambouris, A.M., Trimble, R.P., Top**, D.L., and Nestel, P.J. (1987) The Effects of Dietary Fish Oil on Hepatic HDL and LDL Receptor Activities in the Rat,FEBS Lett. 222, 159–162.
Hannah, J., Kataoka, S., Yamane, K., Schectman, G., Kaul, S., and Howard, B.V. (1993) Effect of Dietary Fatty Acids on LDL Binding,Ann. NY Acad. Sci. 683, 178–182.
Ventura, M.A., Woollett, L.A., and Spady, D.K. (1989) Dietary Fish Oil Stimulates Hepatic Low Density Lipoprotein Transport in the Rat,J. Clin. Invest. 84, 528–537.
Blonk, M.C., Bilo, H.J.G., Nauta, J.J.P., Popp-Snijders, C., Mulder, C., and Donker, A.J.M. (1990) Dose-Response Effects of Fish-Oil Supplementation in Healthy Volunteers,Am. J. Clin. Nutr. 52, 120–127.
Fumeron, F., Brigant, L., Ollivier, V., de Prost, D., Driss, F., Darcet, P., Bard, J.M., Parra, H.J., Fruchart, J.C., and Apfelbaum, M. (1991) n-3 Polyunsaturated Fatty Acids Raise Low-Density Lipoproteins, High-Density Lipoprotein 2, and Plasminogen-Activator Inhibitor in Healthy Young Men,Am. j. Clin. Nutr. 54, 118–122.
Franceschini, G., Calabresi, L., Maderna, P., Galli, C., Gianfranceschi, G., and Sirtori, C.R. (1991) ω-3 Fatty Acids Selectively Raise High-Density Lipoprotein 2 Levels in Healthy Volunteers,Metabolism 40, 1283–1286.
Abbey, M., Clifton, P., Kestin, M., Belling, B., and Nestel, P. (1990) Effect of Fish Oil on Lipoproteins, Lecithin: Cholesterol Acyltransferase, and Lipid Transfer Protein Activity in Humans,Arteriosclerosis 10, 85–94.
Harris, W.S., Windsor, S.L., and Caspermeyer, J.J. (1993) Modification of Lipid-Related Atherosclerosis Risk Factors by ω-3 Fatty Acid Ethyl Esters in Hypertriglyceridemic Patients,J. Nutr. Biochem. 4, 706–712.
Wilson, P.W.F. (1995) Relation of High-Density Lipoprotein Subfractions and Apolipoprotein E Isoforms to Coronary Disease,Clin. Chem. 41, 165–169.
Voss, A., Reinhart, M., Sankarappa, S., and Sprecher, H. (1991) The Metabolism of 7,10,13,16,19-Docosapentaenoic Acid to 4,7,10,13,16,19-Docosahexaenoic Acid in Rat Liver Is Independent of a 4-Desaturase,J. Biol. Chem. 266, 19995–20000.
Adam, O., Wolfram, G., and Zollner, N. (1986) Effect of α-Linolenic Acid in the Human Diet on Linoleic Acid Metabolism and Prostaglandin Biosynthesis,J. Lipid Res. 27, 421–426.
Mest, H.J., Beitz, J., Heinroth, I., Block, H.U., and Forster, W. (1983) The Influence of Linseed Oil Diet on Fatty Acid Pattern in Phospholipids and Thromboxane Formation in Platelts in Man,Klin. Wochenschr. 61, 187–191.
Mantzioris, E., James, M.J., Gibson, R.A., and Cleland, L.G., (1994) Dietary Substitution with an α-Linolenic Acid-Rich Vegetable Oil Increases Eicosapentaenoic Acid Concentrations in Tissues,Am. J. Clin. Nutr. 59, 1304–1309.
von Schacky, C., and Weber, P.C. (1985) Metabolism and Effects on Platelet Function of the Purified Eicosapentaenoic and Docosahexaenoic Acids in Humans,J. Clin. Invest 76, 2446–2450.
Author information
Authors and Affiliations
About this article
Cite this article
Rambjør, G.S., W»len, A.I., Windsor, S.L. et al. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31, S45–S49 (1996). https://doi.org/10.1007/BF02637050
Issue Date:
DOI: https://doi.org/10.1007/BF02637050